DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02196 FOSUN PHARMA

Trading Add to Porfolio
Index Constituent : HS Composite Index, HS Comp. M & S Index, HS Comp.SmallCap Ind, Stock Connect HK Ind, Stock Connect HK MS, Stock Connect HK S I
Major Shareholders [00656] Fosun International Limited (36.65%) Sector Health Care & Biotechnology
Web Site http://www.fosunpharma.com Tel (86 21) 3398-7870
Email ir@fosunpharma.com Fax (86 21) 3398-7871
Related Equities N/A
Principal Activities pharmaceutical and healthcare industry chain, with a focus on the domestic market while expanding globally. Businesses directly operated by the Group include pharmaceutical manufacturing, medical devices and medical diagnosis and healthcare service. The Group also has a presence in pharmaceutical commerce through its investment in Sinopharm.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
The Capital Group Companies, Inc. 38,689,394(L)  7.01(L)  27/08/2018
Edinburgh Partners Limited 32,623,000(L)  6.74(L)  10/07/2018
Wellington Management Group LLP 33,551,238(L) 1,874,213(S)  6.08(L) 0.34(S)  11/12/2018
郭廣昌 30,933,500(L)  5.60(L)  17/01/2019
BlackRock, Inc. 29,114,283(L) 490,000(S)  5.27(L) 0.09(S)  22/02/2019
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
吳以芳 342,000(L)  0.06(L)  07/12/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top